Aqlivia Global Research
Global contract research organization (CRO) offering clinical development, regulatory support, data management, pharmacovigilance and research services with a focus on oncology, immunology and central nervous system (CNS) therapeutic areas. Operates internationally with offices in Europe, India, Japan, Canada and Australia and provides services spanning preclinical toxicology, clinical trial design and execution, biosimilars and formulation research.
Industries
Nr. of Employees
large (251-1000)
Aqlivia Global Research
Products
Consulting Services
Consulting services based on experience and expertise to support clients in finding the best solutions, with a commitment to repeated client engagement.
Recombinant Human Insulin (rh-Insulin)
Aqlivia's biosimilar portfolio includes Recombinant Human Insulin developed using proprietary and recombinant DNA technology for diabetes treatment.
Medical Writing Services
Aqlivia offers medical writing services for pharmaceutical and biotechnology companies, preparing scientifically accurate and culturally sensitive documents compliant with current regulations and adapted to the target audience.
Clinical Monitoring
Monitoring activities conducted by Clinical Research Associates (CRA) to ensure high quality review of study data and effective interaction with study sites during new drug development.
Insulin Glargine
Long-acting biosynthetic human insulin analog manufactured from recombinant DNA technology using yeast Pichia Pastoris, used to maintain basal insulin levels throughout the day.
Insulin Lispro
Short-acting human insulin analog with rapid onset of action, manufactured using recombinant DNA technology, used to stabilize post-meal glucose levels.
Consulting Services
Consulting services based on experience and expertise to support clients in finding the best solutions, with a commitment to repeated client engagement.
Recombinant Human Insulin (rh-Insulin)
Aqlivia's biosimilar portfolio includes Recombinant Human Insulin developed using proprietary and recombinant DNA technology for diabetes treatment.
Medical Writing Services
Aqlivia offers medical writing services for pharmaceutical and biotechnology companies, preparing scientifically accurate and culturally sensitive documents compliant with current regulations and adapted to the target audience.
Clinical Monitoring
Monitoring activities conducted by Clinical Research Associates (CRA) to ensure high quality review of study data and effective interaction with study sites during new drug development.
Insulin Glargine
Long-acting biosynthetic human insulin analog manufactured from recombinant DNA technology using yeast Pichia Pastoris, used to maintain basal insulin levels throughout the day.
Insulin Lispro
Short-acting human insulin analog with rapid onset of action, manufactured using recombinant DNA technology, used to stabilize post-meal glucose levels.
Services
Advisory services across drug development, clinical strategy and regulatory planning.
End-to-end clinical trial services including protocol development, site monitoring, data management, eTMF and study reporting.
Safety monitoring and reporting services for clinical programs.
Statistical planning, analysis, and clinical data management services to support study design and regulatory submissions.
Research collaborations and development of biosimilars, recombinant proteins and monoclonal antibodies.
Safety and efficacy studies for cosmetic, hair, skin and oral care products including claim substantiation.
Advisory services across drug development, clinical strategy and regulatory planning.
End-to-end clinical trial services including protocol development, site monitoring, data management, eTMF and study reporting.
Safety monitoring and reporting services for clinical programs.
Statistical planning, analysis, and clinical data management services to support study design and regulatory submissions.
Research collaborations and development of biosimilars, recombinant proteins and monoclonal antibodies.
Safety and efficacy studies for cosmetic, hair, skin and oral care products including claim substantiation.
Expertise Areas
- Clinical trial management
- Oncology clinical research
- Immunology and autoimmune disease research
- Central nervous system (CNS) research
Key Technologies
- Machine learning / deep learning for clinical analytics
- Electronic trial master file (eTMF)
- Clinical data management systems
- Computed tomography and medical imaging endpoints